More Globe Newswire

View Older Stories View Newer Stories

Oct 15, 2024 08:07AM Douglas Dynamics Announces Third Quarter 2024 Earnings Release and Conference Call
Oct 15, 2024 08:05AM Seanergy Maritime Issues Investor Presentation Highlighting Value Creation Strategy
Oct 15, 2024 08:05AM NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)
Oct 15, 2024 08:05AM MaxCyte Appoints Cynthia Collins to its Board of Directors
Oct 15, 2024 08:04AM Prime Matter Labs Names Four Industry Leaders to New Advisory Board
Oct 15, 2024 08:03AM Taboola Introduces Abby, An Industry First Generative AI Assistant, Enabling Advertisers to “Talk to Abby” to Start and Manage Every Aspect of Advertising Campaigns
Oct 15, 2024 08:03AM Noom Strengthens Healthcare Team by Adding Women’s Health Experts
Oct 15, 2024 08:02AM Microchip Releases 20 Advanced Wi-Fi® Products for Industrial and Commercial Applications
Oct 15, 2024 08:02AM Xometry to Announce Third Quarter 2024 Financial Results On November 5, 2024
Oct 15, 2024 08:00AM WALKER RIVER ANNOUNCES ADDITIONAL RESULTS FROM THE LAPON GOLD PROJECT
Oct 15, 2024 08:00AM Cleanfarms Collecting Unwanted Agricultural Pesticides and Old Livestock/Equine Medications in Southern Alberta starting in October
Oct 15, 2024 08:00AM Franklin Electric Schedules Its Third Quarter 2024 Earnings Release and Conference Call
Oct 15, 2024 08:00AM Xtreme One Entertainment Lets Retail Investors Get into the Fight Game with a $10 million Common Stock Offering to Accelerate its XFC 3-Year Growth Plan
Oct 15, 2024 08:00AM Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
Oct 15, 2024 08:00AM VELUX Group signs long-term agreement with ArcelorMittal to supply low carbon-emission steel
Oct 15, 2024 08:00AM Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
Oct 15, 2024 08:00AM 4VITAHEALTH™ Launches Groundbreaking Mental Health Supplements
Oct 15, 2024 08:00AM BioVie Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin
Oct 15, 2024 08:00AM Local Falcon Introduces Falcon Guard: Safeguarding Google Business Listings Against Unauthorized Changes
Oct 15, 2024 08:00AM Abcourt Completes Channel Sampling of its Second Stripping Phase on its Flordin Property
Oct 15, 2024 08:00AM Central and Northern Virginia Area Hardee’s Raise More than $17,000 for Navy SEAL Foundation
Oct 15, 2024 08:00AM Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
Oct 15, 2024 08:00AM Altimmune to Present New Data on the Lipidomic Profile in Subjects Treated with Pemvidutide at The Liver Meeting® 2024
Oct 15, 2024 08:00AM Advanced Care Group Expands Healthcare Staffing Solutions with New Services and Key Regional Support Initiatives
Oct 15, 2024 08:00AM RTI Awarded Elite Supplier Status by Lockheed Martin’s Rotary and Mission Systems (RMS) Division
Oct 15, 2024 08:00AM Sloane & Company Expands its Healthcare Practice with the Appointment of Managing Director Leslie Wheeler
Oct 15, 2024 08:00AM Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing
Oct 15, 2024 08:00AM InterDigital Announces Date for Third Quarter 2024 Financial Results
Oct 15, 2024 08:00AM Deutsche Telekom and Broadcom expand partnership
Oct 15, 2024 08:00AM IPG Photonics to Announce Third Quarter 2024 Financial Results on October 29
Oct 15, 2024 08:00AM HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi
Oct 15, 2024 08:00AM Core Molding Technologies Announces Timing of Third Quarter Fiscal Year 2024 Results
Oct 15, 2024 08:00AM Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
Oct 15, 2024 08:00AM Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
Oct 15, 2024 08:00AM Tree Island Steel to Issue Third Quarter 2024 Financial Results on November 5, 2024
Oct 15, 2024 08:00AM CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia with Lewy Bodies (DLB)
Oct 15, 2024 08:00AM NetAlly Taps Channel Veteran Jeff McCullough to Drive Partner Sales Growth Across North America
Oct 15, 2024 08:00AM JBTC Announces 3rd Quarter 2024 Earnings
Oct 15, 2024 08:00AM Nametag Unveils Deepfake Defense™ to Combat AI-Powered Impersonation Threats, Expands Integration Partnership with Okta
Oct 15, 2024 08:00AM American Rebel Light Beer Connecticut Launch Party at Toad’s Place Presented by Dichello Distributors
Oct 15, 2024 08:00AM Wellspring Accelerates Growth Trajectory with Key C-Suite Appointments Following Sopheon Acquisition
Oct 15, 2024 08:00AM Palisade Bio Announces Abstract Accepted for Presentation at the American College of Gastroenterology’s (ACG) 2024 Annual Scientific Meeting
Oct 15, 2024 08:00AM Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
Oct 15, 2024 08:00AM Concentrix Positioned as a Leader in Everest Group’s Customer Experience Management (CXM) Services PEAK Matrix® Assessment 2024
Oct 15, 2024 08:00AM Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
Oct 15, 2024 08:00AM Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
Oct 15, 2024 08:00AM ScribeAmerica to Sponsor and Exhibit at the Inaugural AI @ HLTH Pavilion
Oct 15, 2024 08:00AM Apollo Launches Evergreen Secondaries Products for Global Wealth Investors
Oct 15, 2024 08:00AM GoHealth leveraging proprietary technology to help consumers navigate an unprecedented Annual Enrollment Period, as new data shows millions of Medicare beneficiaries face significant plan disruption
Oct 15, 2024 08:00AM Apollo Closes Second Vintage Large Cap Direct Lending Fund with $4.8 Billion of Assets
View Newer Stories View Older Stories